Indian Journal of Surgery

, Volume 81, Issue 6, pp 537–542 | Cite as

Pelvic Exenterations for Cervical Cancer Recurrences—a Safe Option in Indian Scenario

  • P. RemaEmail author
  • S. Suchetha
  • Arun Peter Mathew
  • Preethy George
  • Aleyamma Mathew
  • Shaji Thomas
Original Article


Cervical cancer is still a major health problem in India with majority of patients presenting with locally advanced stages. Management of local recurrences of cervical cancer after chemoradiation is a challenging task. Pelvic exenteration is a radical surgery with en bloc resection of pelvic organs is an accepted treatment modality for local recurrence of cervical cancer. In a low-resource country like India where alternate treatment modalities like chemotherapy and targeted therapy are unaffordable to these patients, this radical surgery may be the only treatment modality which gives long-term survival benefit. The aim of the study is to evaluate the morbidity and survival outcome following pelvic exenteration in patients with recurrent cervical cancer in our institution. After obtaining institutional review board approval, a retrospective audit was conducted of all patients who underwent pelvic exenterative surgery for recurrent cervical cancer in our institution from January 2007 to December 2017. The parameters assessed were age of the patient, histologic type and grade, stage of disease, surgical procedures performed, type of reconstruction, intra-operative complications, length of hospital stay, and post-operative morbidity. Patients were followed until March 2017. Survival time was calculated from the date of surgery to the date of last contact or death. Survival estimation was done by Kaplan-Meier method. Between 2007 and 2017, 30 patients underwent the surgery. Mean age of the cohort was 50.9 years (range 33–67 years). Histological type was squamous cell carcinoma in 23 and adenocarcinoma in 7 patients. Twelve patients had anterior exenteration, one had posterior and 17 had total exenteration. The mean operating time was 367.3 min (210–600 min). No post-operative mortality was observed. Post-operative complications were seen in 66.6% of which the most common was of the urinary tract including 4 patients with recurrent urosepsis, one patient with obstructive uropathy and acute renal failure necessitating laparotomy and ureteric reimplantation. Two patients developed fistulae, one urinary and one bowel. Median follow-up time was 27.5 months (1.8–99.1 months). A five-year overall survival for the cohort was 60.5%. It is suggested that pelvic exenteration is an effective technique with reasonable long-term survival benefit and acceptable morbidity in selected patients with cervical cancer recurrence.


Pelvic exenteration Cervical cancer Recurrences Surgical salvage Radical surgery 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRefGoogle Scholar
  2. 2.
    Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Hsueh S (2004) Recurrent squamous cell carcinoma after definitive radiotherapy. Int J Radiat Oncol Biol Phys 60:249–257CrossRefGoogle Scholar
  3. 3.
    Qiu J-T, Abdullah NA, Chou H-H, Lin C-T, Jung S-M, Wang C-C, Chen M-Y, Huang K-G, Chang T-C, Lai C-H (2012) Outcomes and prognosis of patients with recurrent cervical cancer after radical hysterectomy. Gynecol Oncol 127:472–477CrossRefGoogle Scholar
  4. 4.
    Webb MJ, Symmonds RE (1980) Site of recurrence of cervical cancer after radical hysterectomy. Am J Obstet Gynecol 138(7 Pt 1):813–817CrossRefGoogle Scholar
  5. 5.
    Brunschwig A (1948) Complete excision of pelvic viscera for advanced carcinoma. Cancer 1:177–183CrossRefGoogle Scholar
  6. 6.
    Sharma S, Odunsi K, Driscoll D et al (2005) Pelvic exenteration for gyneco-logical malignancies: twenty-year experience at Rosewell Park Cancer Institute. Int J Gynecol Cancer 15:475–482CrossRefGoogle Scholar
  7. 7.
    Marnitz S, Dowdy S, Lanowska M, Schneider A, Podratz K, Köhler C (2009) Exenterations 60 years after first description: results of a survey among US and German gynecologic oncology centers. Int J Gynecol Cancer 19:974–977CrossRefGoogle Scholar
  8. 8.
    Carter MF, Dalton DP, Garnett JE (1989) Simultaneous diversion of the urinary and fecal streams utilizing a single abdominal stoma: the double-barreled wet colostomy. J Urol 141:1189–1191CrossRefGoogle Scholar
  9. 9.
    Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefGoogle Scholar
  10. 10.
    Averette HE, Lichtinger M, Sevin BU, Girtanner RE (1984) Pelvic exenteration: a 15-year experience in a general metropolitan hospital. Am J Obstet Gynecol 150(2):179–184CrossRefGoogle Scholar
  11. 11.
    Peiretti M, Zapardiel I, Zanagnolo V, Landoni F, Morrow CP, Maggioni A (2012) Management of recurrent cervical cancer: a review of the literature. Surg Oncol 21:e59–e66. CrossRefPubMedGoogle Scholar
  12. 12.
    Chiantera V, Rossi M, De Iaco P et al (2014) Morbidity after pelvic exen-teration for gynecological malignancies: a retrospective multicentric study of 230 patients. Int J Gynecol Cancer : Official J Int Gynecol Cancer Soc 24:156–164CrossRefGoogle Scholar
  13. 13.
    Berek JS, Howe C, Lagasse LD, Hacker NF (2005) Pelvic exenteration for recurrent gynecological malignancy: survival and morbidity analysis of the 45 year experience at UCLA. Gynecol Oncol 99(1):153–159CrossRefGoogle Scholar
  14. 14.
    Schmidt AM, Imesch P, Fink D, Egger H (2012) Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecol Oncol 125(3):604–609CrossRefGoogle Scholar
  15. 15.
    Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, Fields AL (2006) Total pelvic exenteration: the Albert Ein-stein College of Medicine/Montefiore medical center experience. Gynecol Oncol 101:261–268CrossRefGoogle Scholar
  16. 16.
    Bladou F, Houvenaeghel G, Delpero JR et al (1995) Incidence and management of major urinary complications after pelvic exenteration for gynecological malignancies. J Surg Oncol 58:91–96CrossRefGoogle Scholar
  17. 17.
    Soper JT, Berchuck A, Creasman WT, Clarke-Pearson DL (1989) Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol 35:93–98CrossRefGoogle Scholar
  18. 18.
    Carter MF, Dalton DP, Garnett JE (1994) The double barreled wet colostomy: long-term experience with the first 11 patients. J Urol 152(6 pt 2):2312–2315CrossRefGoogle Scholar
  19. 19.
    Golda T, Biondo S, Kreisler E, Frago R, Fraccalvieri D, Millan M (2010) Follow-up of double-barreled wet colostomy after pelvic exenteration at a single institution. Dis Colon Rectum 5(3):822–829CrossRefGoogle Scholar
  20. 20.
    Guimaraes GC, Ferreira FO, Rossi BM, Aguiar S, Zequi SC, Bachega W, Nakagawa WT, Fonseca FP, Sarkis AS, Lopes A (2006) Double-barreled wet colostomy is a safe option for simultaneous urinary and fecal diversion. Analysis of 56 procedures from a single institution. J Surg Oncol 93:206–211CrossRefGoogle Scholar
  21. 21.
    Chokshi RJ, Kuhrt MP, Schmidt C, Arrese D, Routt M, Parks L, Bahnson R, Martin EW Jr (2011) Single institution experience comparing double-barreled wet colostomy to ileal conduit for urinary and fecal diversion. Urology 78:856–862CrossRefGoogle Scholar
  22. 22.
    Shingleton HM, Soong SJ, Gelder MS et al (Jun 1989) Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 73(6):1027–1034PubMedGoogle Scholar

Copyright information

© Association of Surgeons of India 2018

Authors and Affiliations

  • P. Rema
    • 1
    Email author
  • S. Suchetha
    • 1
  • Arun Peter Mathew
    • 2
  • Preethy George
    • 3
  • Aleyamma Mathew
    • 3
  • Shaji Thomas
    • 2
  1. 1.Division of Gynaecological OncologyRegional Cancer CentreThiruvanandapuramIndia
  2. 2.Department of Surgical ServicesRegional Cancer CentreTrivandrumIndia
  3. 3.Department of Epidemiology and BiostatisticsRegional Cancer CentreThiruvanandapuramIndia

Personalised recommendations